The Value of Technetium-99m Labeled Alpha-Melanocyte- Stimulating Hormone (99mTc-α-MSH) in Diagnosis of Primary and Metastatic Lesions of Malignant Melanoma

Objective(s): Malignant melanoma is the most lethal type of skincancers with unfavorable prognosis. Alpha-MSH peptide analogues havea high affinity for melanocortine-1 (MC1) receptors on melanocytes overexpressing in malignant melanoma cells. Pre-clinical studies have shownpromising results for radi...

Full description

Bibliographic Details
Main Authors: Saeed Farzanefar, Rahman Etemadi, Mohammad Shirkhoda, Habibollah Mahmoodzadeh, Mostafa Erfani, Babak Fallahi, Mehrshad Abbasi, Narjess Ayati, Arman Hassanzadeh-Rad, Mohammad Eftekhari, Davood Beiki
Format: Article
Language:English
Published: Mashhad University of Medical Sciences 2018-06-01
Series:Asia Oceania Journal of Nuclear Medicine and Biology
Subjects:
Online Access:http://aojnmb.mums.ac.ir/article_10721_2847c09e8a4a7d8b21ec0ed642ce117b.pdf
id doaj-05639e50dec441dcad59c02eb6325fec
record_format Article
spelling doaj-05639e50dec441dcad59c02eb6325fec2020-11-25T02:00:31ZengMashhad University of Medical SciencesAsia Oceania Journal of Nuclear Medicine and Biology2322-57182322-57262018-06-016215516010.22038/aojnmb.2018.30101.120410721The Value of Technetium-99m Labeled Alpha-Melanocyte- Stimulating Hormone (99mTc-α-MSH) in Diagnosis of Primary and Metastatic Lesions of Malignant MelanomaSaeed Farzanefar0Rahman Etemadi1Mohammad Shirkhoda2Habibollah Mahmoodzadeh3Mostafa Erfani4Babak Fallahi5Mehrshad Abbasi6Narjess Ayati7Arman Hassanzadeh-Rad8Mohammad Eftekhari9Davood Beiki10Department of Nuclear Medicine, Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran, IranResearch Center for Nuclear Medicine, Shariati Hospital, Tehran University of Medical Sciences, Tehran, IranDepartment of General Surgery, Cancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, IranDepartment of General Surgery, Cancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, IranRadiation Application Research School, Nuclear Science and Technology Research Institute, Tehran, IranResearch Center for Nuclear Medicine, Shariati Hospital, Tehran University of Medical Sciences, Tehran, IranDepartment of Nuclear Medicine, Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran, IranNuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, IranResearch Center for Nuclear Medicine, Shariati Hospital, Tehran University of Medical Sciences, Tehran, IranResearch Center for Nuclear Medicine, Shariati Hospital, Tehran University of Medical Sciences, Tehran, IranResearch Center for Nuclear Medicine, Shariati Hospital, Tehran University of Medical Sciences, Tehran, IranObjective(s): Malignant melanoma is the most lethal type of skincancers with unfavorable prognosis. Alpha-MSH peptide analogues havea high affinity for melanocortine-1 (MC1) receptors on melanocytes overexpressing in malignant melanoma cells. Pre-clinical studies have shownpromising results for radiolabeled MSH imaging in this malignancy. Thepurpose of this study is to assess the diagnostic value of 99mTc-α-MSHimaging in malignant melanoma.Methods: Twenty-one patients (13 men) with pathologically confirmedmalignant melanoma with or without metastatic distribution wereincluded in this study. 740-1110 MBq 99mTc-α-MSH was injected and wholebody scans were performed 20, 120 and 240 minutes post injection andwere assessed both qualitatively and semi-quantitatively using target (T)to background (BG) ratio.Results: The T/BG ratio for the primary tumor bed was 2.51±2.26,2.56±2.48 and 1.92±1.79 minutes in the whole body scans 20, 120 and 240minutes post injection, respectively. The sensitivity, specificity, negativeand positive predictive values were 75%, 80%, 50% and 92% for primarylesion and 25%, 100%, 68% and 100% for distant metastasis, respectively.Conclusion: 99mTc-α-MSH is a newly introduced agent for diagnosisof tumoral lesions in malignant melanoma. Our study showed a highsensitivity with this modality in primary lesions as well as lymph nodeinvolvements. However the detection rate was not high in distantmetastasis. The preliminary results are promising especially as a newcomplementary imaging method in management of malignant melanoma.http://aojnmb.mums.ac.ir/article_10721_2847c09e8a4a7d8b21ec0ed642ce117b.pdfMalignant melanoma99mTc-α-MSHMelanocortine-1 receptorMelanocyte stimulating hormoneRadiolabeled peptide
collection DOAJ
language English
format Article
sources DOAJ
author Saeed Farzanefar
Rahman Etemadi
Mohammad Shirkhoda
Habibollah Mahmoodzadeh
Mostafa Erfani
Babak Fallahi
Mehrshad Abbasi
Narjess Ayati
Arman Hassanzadeh-Rad
Mohammad Eftekhari
Davood Beiki
spellingShingle Saeed Farzanefar
Rahman Etemadi
Mohammad Shirkhoda
Habibollah Mahmoodzadeh
Mostafa Erfani
Babak Fallahi
Mehrshad Abbasi
Narjess Ayati
Arman Hassanzadeh-Rad
Mohammad Eftekhari
Davood Beiki
The Value of Technetium-99m Labeled Alpha-Melanocyte- Stimulating Hormone (99mTc-α-MSH) in Diagnosis of Primary and Metastatic Lesions of Malignant Melanoma
Asia Oceania Journal of Nuclear Medicine and Biology
Malignant melanoma
99mTc-α-MSH
Melanocortine-1 receptor
Melanocyte stimulating hormone
Radiolabeled peptide
author_facet Saeed Farzanefar
Rahman Etemadi
Mohammad Shirkhoda
Habibollah Mahmoodzadeh
Mostafa Erfani
Babak Fallahi
Mehrshad Abbasi
Narjess Ayati
Arman Hassanzadeh-Rad
Mohammad Eftekhari
Davood Beiki
author_sort Saeed Farzanefar
title The Value of Technetium-99m Labeled Alpha-Melanocyte- Stimulating Hormone (99mTc-α-MSH) in Diagnosis of Primary and Metastatic Lesions of Malignant Melanoma
title_short The Value of Technetium-99m Labeled Alpha-Melanocyte- Stimulating Hormone (99mTc-α-MSH) in Diagnosis of Primary and Metastatic Lesions of Malignant Melanoma
title_full The Value of Technetium-99m Labeled Alpha-Melanocyte- Stimulating Hormone (99mTc-α-MSH) in Diagnosis of Primary and Metastatic Lesions of Malignant Melanoma
title_fullStr The Value of Technetium-99m Labeled Alpha-Melanocyte- Stimulating Hormone (99mTc-α-MSH) in Diagnosis of Primary and Metastatic Lesions of Malignant Melanoma
title_full_unstemmed The Value of Technetium-99m Labeled Alpha-Melanocyte- Stimulating Hormone (99mTc-α-MSH) in Diagnosis of Primary and Metastatic Lesions of Malignant Melanoma
title_sort value of technetium-99m labeled alpha-melanocyte- stimulating hormone (99mtc-α-msh) in diagnosis of primary and metastatic lesions of malignant melanoma
publisher Mashhad University of Medical Sciences
series Asia Oceania Journal of Nuclear Medicine and Biology
issn 2322-5718
2322-5726
publishDate 2018-06-01
description Objective(s): Malignant melanoma is the most lethal type of skincancers with unfavorable prognosis. Alpha-MSH peptide analogues havea high affinity for melanocortine-1 (MC1) receptors on melanocytes overexpressing in malignant melanoma cells. Pre-clinical studies have shownpromising results for radiolabeled MSH imaging in this malignancy. Thepurpose of this study is to assess the diagnostic value of 99mTc-α-MSHimaging in malignant melanoma.Methods: Twenty-one patients (13 men) with pathologically confirmedmalignant melanoma with or without metastatic distribution wereincluded in this study. 740-1110 MBq 99mTc-α-MSH was injected and wholebody scans were performed 20, 120 and 240 minutes post injection andwere assessed both qualitatively and semi-quantitatively using target (T)to background (BG) ratio.Results: The T/BG ratio for the primary tumor bed was 2.51±2.26,2.56±2.48 and 1.92±1.79 minutes in the whole body scans 20, 120 and 240minutes post injection, respectively. The sensitivity, specificity, negativeand positive predictive values were 75%, 80%, 50% and 92% for primarylesion and 25%, 100%, 68% and 100% for distant metastasis, respectively.Conclusion: 99mTc-α-MSH is a newly introduced agent for diagnosisof tumoral lesions in malignant melanoma. Our study showed a highsensitivity with this modality in primary lesions as well as lymph nodeinvolvements. However the detection rate was not high in distantmetastasis. The preliminary results are promising especially as a newcomplementary imaging method in management of malignant melanoma.
topic Malignant melanoma
99mTc-α-MSH
Melanocortine-1 receptor
Melanocyte stimulating hormone
Radiolabeled peptide
url http://aojnmb.mums.ac.ir/article_10721_2847c09e8a4a7d8b21ec0ed642ce117b.pdf
work_keys_str_mv AT saeedfarzanefar thevalueoftechnetium99mlabeledalphamelanocytestimulatinghormone99mtcamshindiagnosisofprimaryandmetastaticlesionsofmalignantmelanoma
AT rahmanetemadi thevalueoftechnetium99mlabeledalphamelanocytestimulatinghormone99mtcamshindiagnosisofprimaryandmetastaticlesionsofmalignantmelanoma
AT mohammadshirkhoda thevalueoftechnetium99mlabeledalphamelanocytestimulatinghormone99mtcamshindiagnosisofprimaryandmetastaticlesionsofmalignantmelanoma
AT habibollahmahmoodzadeh thevalueoftechnetium99mlabeledalphamelanocytestimulatinghormone99mtcamshindiagnosisofprimaryandmetastaticlesionsofmalignantmelanoma
AT mostafaerfani thevalueoftechnetium99mlabeledalphamelanocytestimulatinghormone99mtcamshindiagnosisofprimaryandmetastaticlesionsofmalignantmelanoma
AT babakfallahi thevalueoftechnetium99mlabeledalphamelanocytestimulatinghormone99mtcamshindiagnosisofprimaryandmetastaticlesionsofmalignantmelanoma
AT mehrshadabbasi thevalueoftechnetium99mlabeledalphamelanocytestimulatinghormone99mtcamshindiagnosisofprimaryandmetastaticlesionsofmalignantmelanoma
AT narjessayati thevalueoftechnetium99mlabeledalphamelanocytestimulatinghormone99mtcamshindiagnosisofprimaryandmetastaticlesionsofmalignantmelanoma
AT armanhassanzadehrad thevalueoftechnetium99mlabeledalphamelanocytestimulatinghormone99mtcamshindiagnosisofprimaryandmetastaticlesionsofmalignantmelanoma
AT mohammadeftekhari thevalueoftechnetium99mlabeledalphamelanocytestimulatinghormone99mtcamshindiagnosisofprimaryandmetastaticlesionsofmalignantmelanoma
AT davoodbeiki thevalueoftechnetium99mlabeledalphamelanocytestimulatinghormone99mtcamshindiagnosisofprimaryandmetastaticlesionsofmalignantmelanoma
AT saeedfarzanefar valueoftechnetium99mlabeledalphamelanocytestimulatinghormone99mtcamshindiagnosisofprimaryandmetastaticlesionsofmalignantmelanoma
AT rahmanetemadi valueoftechnetium99mlabeledalphamelanocytestimulatinghormone99mtcamshindiagnosisofprimaryandmetastaticlesionsofmalignantmelanoma
AT mohammadshirkhoda valueoftechnetium99mlabeledalphamelanocytestimulatinghormone99mtcamshindiagnosisofprimaryandmetastaticlesionsofmalignantmelanoma
AT habibollahmahmoodzadeh valueoftechnetium99mlabeledalphamelanocytestimulatinghormone99mtcamshindiagnosisofprimaryandmetastaticlesionsofmalignantmelanoma
AT mostafaerfani valueoftechnetium99mlabeledalphamelanocytestimulatinghormone99mtcamshindiagnosisofprimaryandmetastaticlesionsofmalignantmelanoma
AT babakfallahi valueoftechnetium99mlabeledalphamelanocytestimulatinghormone99mtcamshindiagnosisofprimaryandmetastaticlesionsofmalignantmelanoma
AT mehrshadabbasi valueoftechnetium99mlabeledalphamelanocytestimulatinghormone99mtcamshindiagnosisofprimaryandmetastaticlesionsofmalignantmelanoma
AT narjessayati valueoftechnetium99mlabeledalphamelanocytestimulatinghormone99mtcamshindiagnosisofprimaryandmetastaticlesionsofmalignantmelanoma
AT armanhassanzadehrad valueoftechnetium99mlabeledalphamelanocytestimulatinghormone99mtcamshindiagnosisofprimaryandmetastaticlesionsofmalignantmelanoma
AT mohammadeftekhari valueoftechnetium99mlabeledalphamelanocytestimulatinghormone99mtcamshindiagnosisofprimaryandmetastaticlesionsofmalignantmelanoma
AT davoodbeiki valueoftechnetium99mlabeledalphamelanocytestimulatinghormone99mtcamshindiagnosisofprimaryandmetastaticlesionsofmalignantmelanoma
_version_ 1724960073937059840